Gláucio Valdameri

Antibiotics: past, present and future

Biotic Interactions in the Rhizosphere: A Diverse Cooperative Enterprise for Plant Productivity

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

Cisplatin in cancer therapy: Molecular mechanisms of action

Brown gold of marginal soil: Plant growth promoting bacteria to overcome plant abiotic stress for agriculture, biofuels and carbon sequestration

Mining Halophytes for Plant Growth-Promoting Halotolerant Bacteria to Enhance the Salinity Tolerance of Non-halophytic Crops

Cytotoxicity of dietary flavonoids on different human cancer types

ROS and the DNA damage response in cancer

Mitochondria and cancer

Chemical ecology of antibiotic production by actinomycetes

Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy

Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance

Preparation and in vitro evaluation of apigenin-loaded polymeric micelles

Induction of NRF2‐mediated gene expression by dietary phytochemical flavones apigenin and luteolin

New Findings on Breast Cancer Stem Cells: A Review

The Therapeutic Potential of Apigenin

Phomopsichin A–D; Four New Chromone Derivatives from Mangrove Endophytic Fungus Phomopsis sp. 33#

Chromone: A Valid Scaffold in Medicinal Chemistry

Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment

Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function

Marine natural products

Reactive Oxygen Species (ROS)-Based Nanomedicine

Flavonoids in Cancer and Apoptosis

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Salinity tolerance of crops – what is the cost?

antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline

6‐Halogenochromones Bearing Tryptamine: One‐Step Access to Potent and Highly Selective Inhibitors of Breast Cancer Resistance Protein

Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells

Targeting the Multidrug ABCG2 Transporter with Flavonoidic Inhibitors: In Vitro Optimization and In Vivo Validation

New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2

Dual RNA-seq transcriptional analysis of wheat roots colonized by Azospirillum brasilense reveals up-regulation of nutrient acquisition and cell cycle genes

Comparative Proteomics Analysis of the Rice Roots Colonized byHerbaspirillum seropedicaeStrain SmR1 Reveals Induction of the Methionine Recycling in the Plant Host

Investigation of Chalcones as Selective Inhibitors of the Breast Cancer Resistance Protein: Critical Role of Methoxylation in both Inhibition Potency and Cytotoxicity

ABCG2: Recent Discovery of Potent and Highly Selective Inhibitors

Substituted Chromones as Highly Potent Nontoxic Inhibitors, Specific for the Breast Cancer Resistance Protein